Geordie AI, a British security and governance platform for AI agents, today announced it has closed a €25 million ($30 million) Series A round to enhance the product’s capabilities for security and AI teams as they grapple with the emerging adoption and risk AI agents pose.
The round was led by Balderton Capital and included participation from Crosspoint Capital, as well as follow-on investment from existing investors General Catalyst and Ten Eleven Ventures, bringing total funding to €31.3 million ($36.5 million).
Geordie will expand engineering and go-to-market teams, with a focus on expanding its US operations.
“The organisations today that can safely approve and deploy AI agents are the ones that are capturing a new competitive advantage in their space,” says Henry Comfort, CEO and co-founder of Geordie AI. “Geordie enables teams to take a holistic, defense in depth approach so they can deploy their AI agent systems safely at scale.”
Relevant 2026 funding rounds in similar verticals:
- Overmind – London, UK – €2.3 million Seed – to grow technical teams, accelerate product development and scale go-to-market for its AI-agent supervision layer. Same country as Geordie.
- Trent AI – London, UK – €11 million Seed – to build layered security for agentic systems and autonomous workflows. Same country as Geordie.
- Nexus – Brussels, Belgium – €3.7 million Seed – to scale an agentic AI platform for enterprise deployment of autonomous agents. General Catalyst, also an investor in Geordie, led the round.
- Modern Relay – Barcelona / San Francisco, Spain / US – €2.5 million – to build an enterprise AI foundation layer for context, coordination and governance across agents.
- Logicc – Hamburg, Germany – €2.5 million Seed – to develop a secure AI platform for lawyers, doctors and public institutions handling sensitive data.
- QuoIntelligence – Frankfurt, Germany – €7.3 million Series A – to support go-to-market expansion, product development and team growth for EU-compliant threat intelligence.
- Test of Things – Finland – €1.2 million pre-Seed – to automate cybersecurity compliance testing for connected products and services.
Taken together, these 2026 announcements above represent approximately €30.5 million in disclosed funding across AI-agent security, secure enterprise AI, AI governance infrastructure and adjacent cybersecurity.
The closest UK comparables are Overmind and Trent AI, both London-based, which indicates that Geordie’s raise sits within an active domestic cluster of startups focused on securing, supervising and governing agentic AI deployments. More broadly, the 2026 coverage points to capital moving into the operational layer around enterprise AI: supervision, risk intelligence, secure deployment, compliance, and shared infrastructure for agents rather than model development alone.
EU-Startups has also previously covered Geordie, including it in a 2026 list of promising British early-stage startups; reporting Geordie had already raised more than €9.6 million.
Mark Crane, Partner at General Catalyst, adds: “When we backed Geordie at Seed, agentic AI security was still a hypothesis. In just six months, AI agents have moved from pilot to production faster than most enterprises were ready for. Geordie’s growth in that short time confirms that Henry, Hanah, and Benji correctly identified that trajectory and we are excited to continue to invest in them.”
AI agents are quickly becoming the primary mechanism through which enterprises operationalise AI. However, the company explains that security and IT teams fundamentally lack the visibility, governance, and operational controls required to deploy AI agents safely at scale.
Founded in 2025, Geordie is a security and governance platform that enables enterprises to understand, secure, and govern their AI agents, giving enterprises a real-time understanding of which agents exist, what they can access, how they behave, and the risks they create across enterprise systems.
Combined with Beam, Geordie’s runtime remediation suite that leverages context engineering, Geordie aims to enable organisations to proactively shape and constrain agent behaviour without slowing innovation.
At Owkin, an AI-first drug discovery and biomedical research company running hundreds of agents across more than 50 petabytes of data, a single Geordie POC allowed them to avert exposure that, according to their own risk quantification methodology, totalled between €10 – €11 million ($12 – $13 million).
“For us, AI agents are a necessity to our competitive advantage. We chose Geordie because of its purpose-built approach, which doesn’t risk the business innovation that started our AI agent journey in the first place,” says Leo Cunningham, CISO, Owkin. “We’re seeing the iceberg that rocked the Titanic weeks in advance rather than the moment it appears on screen.”
